ALL
-
2017.05.17
News
[Press Release] Universal Cells, Inc’s Gene Editing Strategy Published in Nature Biotechnology
-
2017.03.23
News
[Press Release] The Results from Athersys’ Phase 2 Trial of MultiStem Cell Therapy for Treating Ischemic Stroke Patients in the United States and Europe Published in Lancet Neurology
-
2017.01.31
News
[Press Release]Announcement on transfer of business relating to ophthalmic surgical adjuvant containing BBG250
-
2017.01.11
News
Presentation at 2017 JP Morgan Healthcare Conference on Wednesday January 11, 2017 at 4:00pm PT (Webcast available)
-
2016.10.17
News
Healios to participate in a webcast on innovating for ophthalmic diseases on October 20
-
2016.08.31
News
[Press Release] HEALIOS Plans to Start a Clinical Trial of HLCM051 in Patients with Ischemic Stroke in Japan
-
2016.07.06
Topics
Panelist at Bloomberg seminar on July 7th
-
2016.06.28
Media
CEO Kagimoto’s comments on Bloomberg news
-
2016.06.02
Topics
Panel discussion at BIO 2016 in San Francisco, CA
-
2016.05.31
News
Interview about the Partnership with Athersys
-
2017.06.05
News
Holding a Focus Session in ISSCR 2017 in Boston
-
2017.05.17
News
[Press Release] Universal Cells, Inc’s Gene Editing Strategy Published in Nature Biotechnology
-
2017.03.23
News
[Press Release] The Results from Athersys’ Phase 2 Trial of MultiStem Cell Therapy for Treating Ischemic Stroke Patients in the United States and Europe Published in Lancet Neurology
-
2017.01.31
News
[Press Release]Announcement on transfer of business relating to ophthalmic surgical adjuvant containing BBG250
-
2017.01.11
News
Presentation at 2017 JP Morgan Healthcare Conference on Wednesday January 11, 2017 at 4:00pm PT (Webcast available)
-
2016.10.17
News
Healios to participate in a webcast on innovating for ophthalmic diseases on October 20
-
2016.08.31
News
[Press Release] HEALIOS Plans to Start a Clinical Trial of HLCM051 in Patients with Ischemic Stroke in Japan
-
2016.07.06
News
Panelist at Bloomberg seminar on July 7th
-
2016.06.28
News
CEO Kagimoto’s comments on Bloomberg news
-
2016.06.02
News
Panel discussion at BIO 2016 in San Francisco, CA